Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation

Surv Ophthalmol. 1995 Nov-Dec;40(3):197-206. doi: 10.1016/s0039-6257(95)80026-3.

Abstract

We present a clinical pathological review of vitreous amyloidosis in a case of familial amyloidotic polyneuropathy, type I. Vitreous opacification was the first manifestation of disease in the proband, who was successfully treated with vitrectomy. The eyes were obtained at autopsy after the patient died from an unrelated cause, and the histopathology is presented here. Analysis of DNA from the pathology specimen revealed the most commonly reported transthyretin mutation, Val30Met. The classification of systemic and ocular amyloidosis as well as the genetics of familial amyloidotic polyneuropathy are briefly reviewed.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Amyloid / genetics*
  • Amyloid Neuropathies / genetics
  • Amyloid Neuropathies / pathology*
  • Amyloid Neuropathies / surgery
  • Base Sequence
  • DNA / analysis
  • DNA / chemistry
  • DNA Primers / chemistry
  • Eye Diseases / genetics
  • Eye Diseases / pathology
  • Eye Diseases / surgery
  • Humans
  • Male
  • Molecular Sequence Data
  • Point Mutation*
  • Prealbumin / genetics*
  • Vitrectomy
  • Vitreous Body / pathology*

Substances

  • Amyloid
  • DNA Primers
  • Prealbumin
  • amyloid prealbumin
  • DNA